Pan-India IVF and fertility-care chain operating a hub-and-spoke network of clinics with AI-assisted embryology, offering IVF treatment, hospital care and pharmacy services under the Gaudium IVF brand.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 1 | 1 | 1 | 31 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 28 | 116 |
| Borrowings | 6 | 12 | 17 | 21 | 24 | 25 |
| Other Liabilities | 3 | 2 | 7 | 22 | 24 | 16 |
| Total Liabilities | 18 | 37 | 51 | 89 | 107 | 193 |
| AssetsFixed Assets | 4 | 18 | 19 | 18 | 30 | 30 |
| CWIP | 0 | 0 | 0 | 7 | 0 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 | 5 |
| Other Assets | 14 | 18 | 32 | 58 | 72 | 158 |
| Total Assets | 18 | 37 | 51 | 89 | 107 | 193 |
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ActivitiesCash from Operating | -1 | 24 | 3 | 9 | 7 |
| Cash from Investing | -1 | -16 | -5 | -15 | -88 |
| Cash from Financing | 3 | 5 | -1 | 2 | 82 |
| SummaryCapital Expenditure | — | — | — | — | — |
| Free Cash Flow | -2 | 9 | 1 | 0 | 5 |
| FCF Margin | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (16.6×) and current (35.2×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 10% growth and a 17× exit, ₹152 only delivers your return if you pay ₹51. The price is currently baking in 34% growth.
EPS grows 10%/yr for 5 years, then fades to 6% over 2, exits at 17×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 10.0% | 4.75 |
| FY28 | 10.0% | 5.23 |
| FY29 | 10.0% | 5.75 |
| FY30 | 10.0% | 6.32 |
| FY31 | 10.0% | 6.96 |
| FY32 | 8.0% ·fade | 7.51 |
| FY33 | 6.0% ·fade | 7.96 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.